enow.com Web Search

  1. Ads

    related to: alzheimer's medication that improve memory issues and anxiety and depression

Search results

  1. Results from the WOW.Com Content Network
  2. Memantine - Wikipedia

    en.wikipedia.org/wiki/Memantine

    Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. [ 10 ][ 11 ][ 8 ] It is taken by mouth. [ 10 ][ 8 ] Common side effects include headache, constipation, sleepiness, and dizziness. [ 10 ][ 11 ] Severe side effects may include blood clots, psychosis ...

  3. FDA approves Alzheimer’s treatment that has been shown to ...

    www.aol.com/news/fda-approves-alzheimer...

    The FDA approved a new Alzheimer’s drug that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities. The FDA approved a new Alzheimer’s drug that has ...

  4. A Revolutionary New Alzheimer’s Drug Was Just Approved by the ...

    www.aol.com/revolutionary-alzheimer-drug-just...

    For premium support please call: 800-290-4726 more ways to reach us

  5. Aducanumab - Wikipedia

    en.wikipedia.org/wiki/Aducanumab

    Aducanumab is a monoclonal IgG1 antibody that binds to the amyloid beta protein at amino acids 3–7, which is posited to result in slowing the progression of Alzheimer's disease. [ 5 ] The mechanism is based on the amyloid hypothesis, which posits that amyloid proteins cause Alzheimer's disease, hence removing amyloid should slow the ...

  6. Alzheimer's disease - Wikipedia

    en.wikipedia.org/wiki/Alzheimer's_disease

    Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens, [2] and is the cause of 60–70% of cases of dementia. [2][15] The most common early symptom is difficulty in remembering recent events. [1] As the disease advances, symptoms can include problems with language, disorientation (including ...

  7. ALTO-100 - Wikipedia

    en.wikipedia.org/wiki/ALTO-100

    ALTO-100. ALTO-100, previously known as NSI-189 (NeuralStem Inc. 189), [3] is a drug described as a hippocampal neurogenesis stimulant and indirect brain-derived neurotrophic factor (BDNF) modulator which is under development for the treatment of major depressive disorder (MDD), bipolar depression, and post-traumatic stress disorder (PTSD). [4 ...

  1. Ads

    related to: alzheimer's medication that improve memory issues and anxiety and depression